Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Hematology/ Oncology, Duke University School of Medicine 1990 - 1993
  • Resident, Internal Medicine, Montefiore Medical Center 1987 - 1990
  • M.D., U Mass Memorial Medical Center 1987
• 

  Duke Appointment History

  • Associate Clinical Professor of Medicine, Medicine, Medical Oncology, Medicine 2005 - 2006
  • Assistant Clinical Professor of Medicine, Medicine, Medical Oncology, Medicine 2004 - 2005
  • Assistant Professor of Medicine, Medicine, Medical Oncology, Medicine 1994 - 2003
• Research
• 

  Selected Grants

  • NCI National Clinical Trials Network (UG1) awarded by National Institutes of Health 2019 - 2025
  • Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients awarded by National Institutes of Health 2016 - 2021
  • MaRCC-Sutton 2015 - 2020
  • A Self-Management Intervention for Women with Breast Cancer and Diabetes 2016 - 2020
  • Public Health Surveillance of Bleeding 2011 - 2016
  • A Quality Improvement Approach to the Management of CLL--Research 2015 - 2016
  • Caregiver-Assisting Coping Skills Training for Lung Cancer awarded by National Institutes of Health 2002 - 2008
  • Spouse Guided Pain Management Training for Cancer Pain awarded by National Institutes of Health 2000 - 2003
  • Spore In Breast Cancer awarded by National Institutes of Health 1995 - 1998
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Muss, Hyman B., Mei-Yin C. Polley, Donald A. Berry, Heshan Liu, Constance T. Cirrincione, Maria Theodoulou, Ann M. Mauer, et al. “Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial..” J Clin Oncol, July 24, 2019. https://doi.org/10.1200/JCO.19.00647.
       Full Text  Link to Item
    • Shelby, Rebecca A., Caroline S. Dorfman, Hayden B. Bosworth, Francis Keefe, Linda Sutton, Lynda Owen, Leonor Corsino, et al. “Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)..” Contemp Clin Trials 76 (January 2019): 120–31. https://doi.org/10.1016/j.cct.2018.11.010.
       Full Text  Link to Item
    • Pollak, Kathryn I., Laura J. Fish, Linda M. Sutton, Xiaomei Gao, Pauline Lyna, Lynda Owen, Michele L. Patel, and Tamara J. Somers. “A smoking cessation and pain management program for cancer survivors..” J Cancer Surviv 12, no. 6 (December 2018): 821–27. https://doi.org/10.1007/s11764-018-0719-3.
       Full Text  Link to Item
    • Gajra, Ajeet, Linda McCall, Hyman B. Muss, Harvey J. Cohen, Aminah Jatoi, Karla V. Ballman, Ann H. Partridge, et al. “The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance)..” J Geriatr Oncol 9, no. 3 (May 2018): 221–27. https://doi.org/10.1016/j.jgo.2018.02.003.
       Full Text  Link to Item
    • Dans, Maria, Thomas Smith, Anthony Back, Justin N. Baker, Jessica R. Bauman, Anna C. Beck, Susan Block, et al. “NCCN Guidelines Insights: Palliative Care, Version 2.2017..” J Natl Compr Canc Netw 15, no. 8 (August 2017): 989–97. https://doi.org/10.6004/jnccn.2017.0132.
       Full Text  Link to Item
    • Levy, Michael, Thomas Smith, Amy Alvarez-Perez, Anthony Back, Justin N. Baker, Anna C. Beck, Susan Block, et al. “Palliative Care Version 1.2016..” J Natl Compr Canc Netw 14, no. 1 (January 2016): 82–113.
       Link to Item
    • Sutton, Linda M., Joseph Geradts, Erika P. Hamilton, Kathleen A. Havlin, Gretchen G. Kimmick, P Kelly Marcom, Neil L. Spector, et al. “CHAMBER: A Regional Performance Improvement CME Initiative for Breast Cancer Health Care Providers..” J Natl Compr Canc Netw 13, no. 8 (August 2015): 1005–11.
       Link to Item
    • Levy, Michael H., Thomas Smith, Amy Alvarez-Perez, Anthony Back, Justin N. Baker, Susan Block, Shirley N. Codada, et al. “Palliative care, Version 1.2014. Featured updates to the NCCN Guidelines..” J Natl Compr Canc Netw 12, no. 10 (October 2014): 1379–88.
       Link to Item
    • Stevenson, Marvaretta M., Tonia Irwin, Terry Lowry, Maleka Z. Ahmed, Thomas L. Walden, Melanie Watson, and Linda Sutton. “Development of a virtual multidisciplinary lung cancer tumor board in a community setting..” J Oncol Pract 9, no. 3 (May 2013): e77–80. https://doi.org/10.1200/JOP.2013.000882.
       Full Text  Link to Item
    • Levy, Michael H., Michael D. Adolph, Anthony Back, Susan Block, Shirley N. Codada, Shalini Dalal, Teresa L. Deshields, et al. “Palliative care..” J Natl Compr Canc Netw 10, no. 10 (October 1, 2012): 1284–1309.
       Link to Item
    • Altomare, Ivy, Johanna C. Bendell, Karen E. Bullock, Hope E. Uronis, Michael A. Morse, S David Hsu, S Yousuf Zafar, et al. “A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer..” Oncologist 16, no. 8 (2011): 1131–37. https://doi.org/10.1634/theoncologist.2011-0078.
       Full Text  Link to Item
    • Porter, Laura S., Francis J. Keefe, Jennifer Garst, Donald H. Baucom, Colleen M. McBride, Daphne C. McKee, Linda Sutton, et al. “Caregiver-assisted coping skills training for lung cancer: results of a randomized clinical trial..” J Pain Symptom Manage 41, no. 1 (January 2011): 1–13. https://doi.org/10.1016/j.jpainsymman.2010.04.014.
       Full Text  Link to Item
    • Gasparetto, Cristina, Jon P. Gockerman, Louis F. Diehl, Carlos M. de Castro, Joseph O. Moore, Gwynn D. Long, Mitchell E. Horwitz, et al. “"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma..” Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70–77. https://doi.org/10.1016/j.bbmt.2009.08.017.
       Full Text  Link to Item
    • Levy, Michael H., Anthony Back, Costantino Benedetti, J Andrew Billings, Susan Block, Barry Boston, Eduardo Bruera, et al. “NCCN clinical practice guidelines in oncology: palliative care..” J Natl Compr Canc Netw 7, no. 4 (April 2009): 436–73.
       Link to Item
    • Rincon, Mercedes, Gloria Broadwater, Lyndsay Harris, Abigail Crocker, Donald Weaver, Lynn Dressler, Donald Berry, et al. “Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806..” Breast Cancer Res Treat 100, no. 3 (December 2006): 301–8. https://doi.org/10.1007/s10549-006-9251-7.
       Full Text  Link to Item
    • Levy, Michael H., Anthony Back, Sadaf Bazargan, Costantino Benedetti, J Andrew Billings, Susan Block, Eduardo Bruera, et al. “Palliative care. Clinical practice guidelines in oncology..” J Natl Compr Canc Netw 4, no. 8 (September 2006): 776–818.
       Link to Item
    • Keefe, Francis J., Tim A. Ahles, Linda Sutton, JoAnn Dalton, Don Baucom, Mary Susan Pope, Verena Knowles, et al. “Partner-guided cancer pain management at the end of life: a preliminary study..” J Pain Symptom Manage 29, no. 3 (March 2005): 263–72. https://doi.org/10.1016/j.jpainsymman.2004.06.014.
       Full Text  Link to Item
    • Keefe, Francis J., Tim A. Ahles, Laura S. Porter, Linda M. Sutton, Colleen M. McBride, Mary Susan Pope, Elizabeth T. McKinstry, Charlotte P. Furstenberg, JoAnn Dalton, and Donald H. Baucom. “The self-efficacy of family caregivers for helping cancer patients manage pain at end-of-life..” Pain 103, no. 1–2 (May 2003): 157–62. https://doi.org/10.1016/s0304-3959(02)00448-7.
       Full Text  Link to Item
    • Sutton, Linda M., Wendy Demark-Wahnefried, and Elizabeth C. Clipp. “Management of terminal cancer in elderly patients..” Lancet Oncol 4, no. 3 (March 2003): 149–57.
       Link to Item
    • Sutton, Linda M., Laura S. Porter, and Francis J. Keefe. “Cancer pain at the end of life: a biopsychosocial perspective..” Pain 99, no. 1–2 (September 2002): 5–10. https://doi.org/10.1016/s0304-3959(02)00236-1.
       Full Text  Link to Item
    • Rivera, Edgardo, Linda Sutton, Bruce Colwell, Mark Graham, Debra Frye, Matt Somerville, Heather S. Conklin, Chip McGuirt, Jeremey Levin, and Gabriel N. Hortobagyi. “Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer..” J Clin Oncol 20, no. 4 (February 15, 2002): 987–93. https://doi.org/10.1200/JCO.2002.20.4.987.
       Full Text  Link to Item
    • Bastian, L., G. Couchman, B. K. Rimer, C. M. McBride, L. Sutton, and I. C. Siegler. “Promoting informed decision making: hormone replacement therapy..” Cancer Treat Res 97 (1998): 129–47.
       Link to Item
    • Warmuth, M. A., L. M. Sutton, and E. P. Winer. “A review of hereditary breast cancer: from screening to risk factor modification..” Am J Med 102, no. 4 (April 1997): 407–15. https://doi.org/10.1016/s0002-9343(97)00093-4.
       Full Text  Link to Item
    • Sutton, L. M., M. A. Warmuth, W. P. Petros, and E. P. Winer. “Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial..” Cancer Chemother Pharmacol 40, no. 4 (1997): 335–41. https://doi.org/10.1007/s002800050666.
       Full Text  Link to Item
    • Chu, L., L. M. Sutton, B. L. Peterson, K. A. Havlin, and E. P. Winer. “Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer..” J Infus Chemother 6, no. 4 (1996): 211–16.
       Link to Item
    • Winer, E. P., and L. M. Sutton. “Quality of life after bone marrow transplantation..” Oncology (Williston Park) 8, no. 1 (January 1994): 19–27.
       Link to Item

  • Conference Papers

    • Dorfman, C. S., S. A. Kelleher, J. G. Winger, R. A. Shelby, B. E. Thorn, L. M. Sutton, F. J. Keefe, V. Gandhi, P. Manohar, and T. J. Somers. “Development and pilot testing of an mHealth behavioral cancer pain protocol for medically underserved communities.” In Journal of Psychosocial Oncology, 37:335–49, 2019. https://doi.org/10.1080/07347332.2018.1479327.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.